Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Long-Term Debt Repayments (2016 - 2017)

Sanara MedTech (SMTI) has disclosed Long-Term Debt Repayments for 7 consecutive years, with $187416.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Long-Term Debt Repayments fell 4.77% year-over-year to $187416.0, compared with a TTM value of $187416.0 through Sep 2018, down 6.4%, and an annual FY2017 reading of $190838.0, down 4.75% over the prior year.
  • Long-Term Debt Repayments was $187416.0 for Q4 2017 at Sanara MedTech, up from $1149.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $1.1 million in Q4 2015 and bottomed at -$65025.0 in Q1 2013.
  • Average Long-Term Debt Repayments over 4 years is $118847.9, with a median of $1181.5 recorded in 2016.
  • The sharpest move saw Long-Term Debt Repayments surged 87.96% in 2013, then tumbled 82.06% in 2016.
  • Year by year, Long-Term Debt Repayments stood at -$65025.0 in 2013, then surged by 1786.9% to $1.1 million in 2015, then crashed by 82.06% to $196805.0 in 2016, then dropped by 4.77% to $187416.0 in 2017.
  • Business Quant data shows Long-Term Debt Repayments for SMTI at $187416.0 in Q4 2017, $1149.0 in Q3 2017, and $1147.0 in Q2 2017.